Therefore, Rspo3, locally in the liver, functions as a key molecule suppressing the progression of obesity-related fatty liver, and possesses an inherent ability to influence the systemic management of body composition, leading to maintenance of glucose metabolism at the whole-body level. The gene discussed is RSPO3; the disease is obesity disorder.